Trial NCT00491738

View at ClinicalTrials.gov 
Org. Study IDs: AVF4167g

Last trial update was posted on 2009-04-10

MeSH Interventions

Bevacizumab Sunitinib

MeSH Conditions

Carcinoma, Renal Cell

Other Conditions

Renal Cell Carcinoma

Stopping Reasons

Based on the data collected, the combination of bevacizumab and sunitinib appeared to be poorly tolerated.

Limitations And Caveats

Based on the early safety results from this study, Genentech terminated further recruitment and discontinued treatment. Insufficient efficacy information was available to perform additional outcome analyses.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID